Injective (INJ) Faces Steep Decline Amid Market-Wide Correction

Injective (INJ) has emerged as one of the most impacted large-cap altcoins in the current market downturn, witnessing a sharp double-digit price drop in a single day. As broader crypto sentiment shifts toward risk aversion, the token's struggle to find a bottom highlights a growing hesitation among investors to engage with volatile assets during periods of high uncertainty.

Fading Momentum and Technical Breaches

Over the past 24 hours, INJ has shed approximately 19% of its value, a movement that has pushed the token below critical EMA support levels. Unlike typical market pullbacks where lower prices often attract "dip buyers," the current trend shows a simultaneous decline in both price and trading volume, which has recently fallen to $174 million. This lack of participation suggests that traders are opting for the sidelines rather than attempting to catch a falling knife, effectively leaving the path of least resistance firmly to the downside.

Seller Dominance and the Road to Recovery

The prevailing market structure remains bearish, with retail traders contributing significantly to the ongoing selling pressure. While short-term relief rallies are statistically probable after such a steep decline, there is currently little evidence of a sustained bullish reversal. For INJ to regain its footing, the market requires a stabilization of sentiment and a return of meaningful buying volume. Until the current selling pressure exhausts itself, bulls are less focused on a breakout and are instead looking for definitive signs that the slide is finally beginning to slow.